Synthetic Biologics, Inc Press Releases

SYN 
$1.48
*  
0.02
1.37%
Get SYN Alerts
*Delayed - data as of Dec. 26, 2014  -  Find a broker to begin trading SYN now
Exchange: AMEX
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection
12/22/2014 6:58:00 AM - PR Newswire
▼-2.63 % Price Change since this news event. The Volume Ratio is 34.55.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Synthetic Biologics Announces First Patient Dosed in Phase 1a Clinical Trial of SYN-004 for the Prevention of C. difficile Infection
12/2/2014 8:04:00 AM - PR Newswire
▼-10.84 % Price Change since this news event. The Volume Ratio is 1.61.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Synthetic Biologics Safe-to-Proceed Under IND to Initiate Clinical Trials of SYN-004 for the Prevention C. difficile Infection
11/24/2014 6:57:00 AM - PR Newswire


Synthetic Biologics Reports Third Quarter 2014 Financial Results and Operational Highlights
11/14/2014 6:56:00 AM - PR Newswire
▲3.50 % Price Change since this news event. The Volume Ratio is 21.85.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Synthetic Biologics to Report Third Quarter 2014 Financial Results
11/6/2014 6:57:00 AM - PR Newswire
▼-1.33 % Price Change since this news event. The Volume Ratio is 8.96.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program
10/22/2014 6:57:00 AM - PR Newswire
▼-10.84 % Price Change since this news event. The Volume Ratio is 1.71.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Synthetic Biologics Appoints Prominent Gastrointestinal (GI) Key Opinion Leaders to Irritable Bowel Syndrome (IBS) Clinical Advisory Board
10/15/2014 6:58:00 AM - PR Newswire
▲2.78 % Price Change since this news event. The Volume Ratio is 0.62.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Synthetic Biologics to Raise $20.7 Million in Registered Direct Offering
10/10/2014 8:55:00 AM - PR Newswire
▲4.96 % Price Change since this news event. The Volume Ratio is 1.46.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day